Analyzing the Future of Veterinary Intravenous (IV) Solutions Market Dynamics 2025-2034: Growth Rate, Trends, and Major Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What CAGR Will the Veterinary Intravenous (IV) Solutions Market Achieve During 2025–2034, and What Does It Indicate?
The market for veterinary intravenous (IV) solutions has experienced robust growth in the last few years. The market is expected to expand from $1.5 billion in 2024 to $1.62 billion in 2025, with a compound annual growth rate (CAGR) of 8.1%. Factors contributing to the growth during the historic period include an upsurge in the establishment of veterinary clinics, increased incidences of dehydration, expansion in livestock farming, growth in the count of companion animals, and advancement in veterinary diagnostics.
The market size for veterinary intravenous (IV) solutions is projected to experience a significant surge in the upcoming years, expanding to $2.19 billion in 2029 with a compound annual growth rate (CAGR) of 7.8%. Several factors contribute to this growth during the forecast period, such as the increased adoption of pet insurance, the rise in animal healthcare spending, an enhanced understanding of animal healthcare, an increase in animal disease cases, and an expansion in pet insurance coverage. The forecast period will likely see certain trends emerging, including technological progression, variety in product formulations, the incorporation of telemedicine, improved veterinary intravenous (IV) delivery systems, and intelligent veterinary intravenous (IV) systems.
Which Drivers Are Expected to Have the Greatest Impact on the Veterinary Intravenous (IV) Solutions Market’s Growth?
The escalation in various animal diseases is predicted to fuel the veterinary intravenous (IV) solutions market’s expansion. These diseases, such as anthrax, leptospirosis, rabies, canine distemper, heartworm disease, and others, impair animals’ health and functionality. Intensive farming practices, wildlife encroachment, and antibiotic resistance are some factors that contribute to this increase. Veterinary IV solutions play a critical role in providing optimal hydration and supporting the overall health of animals with diseases that cause dehydration, such as gastroenteritis or severe infections. For instance, AVMA Publications reported in July 2024 that the number of domestic animals confirmed with rabies in 2022 was around 345, a 10.9% increase from the 311 cases reported in 2021. Hence, the rise in various animal diseases is fueling the veterinary intravenous (IV) solutions market’s growth. The upswing in expenditure on animal health products is anticipated to stimulate the veterinary intravenous (IV) solutions market’s growth. Animal health products include medications, supplements, and treatments used for the betterment or maintenance of an animal’s health. Factors like growing pet ownership, advancements in veterinary care, increasing knowledge of animal health and the necessity for superior disease prevention and treatment options drive the higher spending on these products. Veterinary IV solutions aid this increase in expenditure on animal health products by addressing crucial medical needs and improving veterinary care. As reported by the Republic of Estonia Agency of Medicines in March 2024, the veterinary medicinal products market saw a 6.9% rise in 2023, reaching $20.54 million (18.6 million euros) from $19.21 million (17.40 million euros) in 2022. Thus, the rising expenditure on animal health products is propelling the veterinary intravenous (IV) solutions market’s growth.
Get Your Free Sample of the Global Veterinary Intravenous (IV) Solutions Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=20686&type=smp
Who Are the Key Firms Paving the Way for Growth in the Veterinary Intravenous (IV) Solutions Market?
Major companies operating in the veterinary intravenous (IV) solutions market are:
• Merck & Co. Inc.
• Baxter International Inc.
• Zoetis Inc.
• Fresenius Kabi AG
• Elanco Animal Health Incorporated
What Are the Most Influential Trends Currently Shaping the Veterinary Intravenous (IV) Solutions Market?
Key players in the veterinary intravenous (IV) solutions market are concentrating on the development of innovative products like fluoroquinolone, aimed at enhancing efficacy and security profiles. Fluoroquinolones are a potent category of antibiotics used in both human and veterinary medicine to treat a range of bacterial infections and managed properly to reduce the potential of resistance and side effects. For example, in April 2024, Elanco, a pharmaceutical company from the US, launched Pradalex, a pradofloxacin injection solution that received approval from the US Food and Drug Administration (FDA). This approval for swine is targeted at treating swine respiratory disease (SRD) related to bordetella bronchiseptica, Glaesserella (Haemophilus) parasuis, Pasteurella multocida, streptococcus suis, and mycoplasma hyopneumoniae. Being a 3rd generation fluoroquinolone, Pradalex is classified as a critically important antimicrobial. The medication’s labeling stipulates that its use should be considered only after exploring other non-fluoroquinolone therapeutic alternatives.
Pre-order Your Report for Quick and Easy Delivery!
What Are the Major Segments of the Veterinary Intravenous (IV) Solutions Market and Their Role in Driving Growth?
The veterinary intravenous (IV) solutions market covered in this report is segmented –
1) By Product: Isotonic Crystalloids, Dextrose Solutions, Synthetic Colloids, Natural Colloids, Parenteral Nutrition
2) By Animal Type: Companion Animals, Production Animals
3) By End-User: Veterinary Hospitals And Clinics, Research Institutes, Other End-Users
Subsegments:
1) Isotonic Crystalloids: Normal Saline (0.9% NaCl), Lactated Ringer’s Solution, Dextrose in Water (D5W), Ringer’s Solution, Balanced Electrolyte Solutions
2) Dextrose Solutions: Dextrose 5% in Water (D5W), Dextrose 10% in Water (D10W), Dextrose 20% in Water (D20W), Dextrose 50% in Water (D50W)
3) Synthetic Colloids: Hydroxyethyl Starch (HES), Dextran, Gelatins
4) Natural Colloids: Albumin, Fresh Frozen Plasma (FFP), Blood Products
5) Parenteral Nutrition: Total Parenteral Nutrition (TPN) Solutions, Partial Parenteral Nutrition Solutions, Lipid Emulsions, Amino Acid Solutions
Which Regions Are Essential for the Growth of the Veterinary Intravenous (IV) Solutions Market?
North America was the largest region in the veterinary intravenous (IV) solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary intravenous (IV) solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Is the Scope and Reach of the Veterinary Intravenous (IV) Solutions Market Defined?
Veterinary intravenous (IV) solutions are sterile fluids administered directly into the bloodstream of animals through a vein, typically via an IV catheter. These solutions are used in veterinary medicine to treat dehydration and electrolyte imbalances, deliver medications, or provide nutrients. Veterinary intravenous (IV) solutions are essential for maintaining or restoring the proper fluid and electrolyte balance in animals, especially in illness, surgery, or trauma cases.
Browse Through More Similar Reports By The Business Research Company:
Veterinary Biologics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/veterinary-biologics-global-market-report
Veterinary Hematology Analyzers Global Market Report 2025
Veterinary Telehealth Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/veterinary-telehealth-market
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
